Session 4 – Visceral leishmaniasis: an overview of detection & response

preview_player
Показать описание
Chaired by Suman Rijal (Drugs for Neglected Diseases initiative (DNDi) this session consists of five talks:

  1. F1000
  2. Leishmaniasis (Disease Or Medical Condition)
  3. Visceral Leishmaniasis (Disease Or Medical Condition)
  4. Health (Industry)
Рекомендации по теме
Session 4 – 0:58:48

Session 4 – Visceral leishmaniasis: an overview of detection & response

Michael Miles Improving 0:21:21

Michael Miles Improving diagnostics for visceral leishmaniasis

Visceral leishmaniasis: the 0:16:39

Visceral leishmaniasis: the discovery & clinical landscape

Visceral leishmaniasis audio- 0:22:31

Visceral leishmaniasis audio- session, by Dr Marwa Omar

Current and future 0:21:00

Current and future perspectives for the development of new treatments for visceral leishmaniasis​

New Drugs for 0:49:32

New Drugs for Kinetoplastid Diseases: Sleeping Sickness Chagas & Leishmaniasis

I-TECH India RDLS 1:04:50

I-TECH India RDLS | HIV Visceral Leishmaniasis co-infection | 18-07-2024

Point-of-Care Diagnosis of 0:00:42

Point-of-Care Diagnosis of Visceral Leishmaniasis in India

Leishmaniasis 0:12:52

Leishmaniasis

Drug discovery and 1:19:31

Drug discovery and future development of medicines against visceral leishmaniasis

Have You Heard? 0:04:41

Have You Heard? Getting a leash on visceral leishmaniasis

UPDATE - Point-of-Care 0:07:49

UPDATE - Point-of-Care Diagnosis of Visceral Leishmaniasis in India

2nd LEAP Scientific 4:09:02

2nd LEAP Scientific Conference | 4th November 2021

Topical treatments for 0:14:33

Topical treatments for cutaneous leishmaniasis (Prof Dolores Carrer, INIMEC-CONICET-UNC, Argentina)

Cutaneous leishmaniasis: from 0:16:19

Cutaneous leishmaniasis: from bench to cure (Dr Byron Arana, Head of Cutaneous Leishmaniasis, DNDi)​...

Etiology - Leishmaniasis 0:00:59

Etiology - Leishmaniasis

Diagnostic Challenges in 0:38:37

Diagnostic Challenges in Leishmania & TB & implications for HIV Co-Infection- Steve Reed (ID...

Development of a 0:08:26

Development of a clinical score regarding leishmaniasis in area with a high risk of HIV co-infection

N. Fasel - 0:33:48

N. Fasel - Vaccine considerations, Leishmania antigens

Indian Visceral Leishmaniasis 0:42:19

Indian Visceral Leishmaniasis (Kala-azar) :: Dr. Shyam Sundar :: CMC-MAC 2023

MSF Scientific Days 1:08:20

MSF Scientific Days - Asia 2019 | Kala Azar – Putting the spotlight on the black fever

Out of Hours 0:31:13

Out of Hours with Davies - infectious disease part one - Leishmania

Post-Kala-Azar Dermal Leishmaniasis: 0:26:14

Post-Kala-Azar Dermal Leishmaniasis: In Vivo Veritas.

G. Matlashewski - 0:39:36

G. Matlashewski - Implementation research for elimination of VL